These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11304997)

  • 1. [Clinical relevance of hetero-VRSA in surgical infections].
    Okii K; Takesue Y; Yokoyama T
    Nihon Rinsho; 2001 Apr; 59(4):728-32. PubMed ID: 11304997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection methods for drug-resistant bacteria in routine examination--VISA].
    Kinoshita S; Nakamachi Y
    Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
    Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
    Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Search for Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA) in MRSA strains isolated from clinical samples during 1990s].
    Nakamachi Y; Kinoshita S; Kumagai S
    Kansenshogaku Zasshi; 2000 Aug; 74(8):653-7. PubMed ID: 11019513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection Methods of Glycopeptide-Resistant Staphylococcus aureus I : Susceptibility Testing.
    Hanaki H; Hiramatsu K
    Methods Mol Med; 2001; 48():85-91. PubMed ID: 21374408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
    McDonald LC; Hageman JC
    Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
    Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
    J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran.
    Aligholi M; Emaneini M; Jabalameli F; Shahsavan S; Dabiri H; Sedaght H
    Med Princ Pract; 2008; 17(5):432-4. PubMed ID: 18685289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [VISA and hetero-VISA among Staphylococcus aureus strains isolated from clinical cases].
    Młynarczyk G; Młynarczyk A; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):9-20. PubMed ID: 12185689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
    Inaba Y; Hiramatsu K
    Nihon Rinsho; 1998 Oct; 56(10):2699-705. PubMed ID: 9796340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C; Denis O; Struelens MJ
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
    Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus resistant to vancomycin--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):565-7. PubMed ID: 12139181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin.
    Oliveira GA; Dell'Aquila AM; Masiero RL; Levy CE; Gomes MS; Cui L; Hiramatsu K; Mamizuka EM
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):443-8. PubMed ID: 11583214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.